{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:24:08Z","timestamp":1790389448305,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005630","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100005630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0936-8","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T05:46:27Z","timestamp":1539927987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-9591","authenticated-orcid":false,"given":"Philippe","family":"Le Corvoisier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Gallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Lesault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Audureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ternacle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Ghostine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaele","family":"Arrouasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Bitari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Mouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Dubois-Rand\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Berdeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Ghaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Deux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Teiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"key":"936_CR1","doi-asserted-by":"publisher","first-page":"d8059","DOI":"10.1136\/bmj.d8059","volume":"344","author":"K Smolina","year":"2012","unstructured":"Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012;344:d8059.","journal-title":"BMJ"},{"key":"936_CR2","doi-asserted-by":"crossref","unstructured":"Sulo G, Igland J, Vollset SE, Nygard O, Ebbing M, Sulo E, et al. Heart failure complicating acute myocardial infarction: burden and timing of occurrence. J Am Heart Assoc. 2016;5:1-8.","DOI":"10.1161\/JAHA.115.002667"},{"key":"936_CR3","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","volume":"34","author":"GM Frohlich","year":"2013","unstructured":"Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34:1714\u201322.","journal-title":"Eur Heart J"},{"key":"936_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13:193\u2013209.","journal-title":"Nat Rev Cardiol"},{"key":"936_CR5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/01.RES.0000122392.33172.09","volume":"94","author":"ER Gross","year":"2004","unstructured":"Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94:960\u20136.","journal-title":"Circ Res"},{"key":"936_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1124\/jpet.108.138008","volume":"326","author":"FN Obame","year":"2008","unstructured":"Obame FN, Plin-Mercier C, Assaly R, Zini R, Dubois-Rande JL, Berdeaux A, et al. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther. 2008;326:252\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"936_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2337\/db06-0907","volume":"56","author":"ER Gross","year":"2007","unstructured":"Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes. 2007;56:127\u201336.","journal-title":"Diabetes"},{"key":"936_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4097\/kjae.2011.61.5.358","volume":"61","author":"JM Kim","year":"2011","unstructured":"Kim JM, Jang YH, Kim J. Morphine and remifentanil-induced cardioprotection: its experimental and clinical outcomes. Korean J Anesthesiol. 2011;61:358\u201366.","journal-title":"Korean J Anesthesiol"},{"key":"936_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1399-6576.2009.02145.x","volume":"54","author":"GT Wong","year":"2010","unstructured":"Wong GT, Li R, Jiang LL, Irwin MG. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand. 2010;54:510\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"key":"936_CR10","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/01.CIR.0000036368.63317.1C","volume":"106","author":"H Mahrholdt","year":"2002","unstructured":"Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002;106:2322\u20137.","journal-title":"Circulation"},{"key":"936_CR11","doi-asserted-by":"publisher","first-page":"65A","DOI":"10.1016\/S0735-1097(97)83991-5","volume":"31","author":"NP Xenopoulos","year":"1998","unstructured":"Xenopoulos NP, Leesar M, Bolli R. Morphine mimics ischemic preconditioning in human myocardium during PTCA. JACC. 1998;31:65A Abstract.","journal-title":"JACC"},{"key":"936_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jcin.2009.10.015","volume":"3","author":"I Rentoukas","year":"2010","unstructured":"Rentoukas I, Giannopoulos G, Kaoukis A, Kossyvakis C, Raisakis K, Driva M, et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv. 2010;3:49\u201355.","journal-title":"JACC Cardiovasc Interv"},{"key":"936_CR13","doi-asserted-by":"crossref","unstructured":"Gwag HB, Kim EK, Park TK, Lee JM, Yang JH, Song YB, et al. Cardioprotective effects of intracoronary morphine in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a prospective, Randomized Trial. J Am Heart Assoc. 2017;6:1-9.","DOI":"10.1161\/JAHA.116.005426"},{"key":"936_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/j.jvca.2005.07.036","volume":"20","author":"GS Murphy","year":"2006","unstructured":"Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2006;20:493\u2013502.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"936_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1749-8090-8-76","volume":"8","author":"R Zhang","year":"2013","unstructured":"Zhang R, Shen L, Xie Y, Gen L, Li X, Ji Q. Effect of morphine-induced postconditioning in corrections of tetralogy of fallot. J Cardiothorac Surg. 2013;8:76.","journal-title":"J Cardiothorac Surg"},{"key":"936_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.jvca.2009.09.012","volume":"24","author":"GT Wong","year":"2010","unstructured":"Wong GT, Huang Z, Ji S, Irwin MG. Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2010;24:790\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"936_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/eurheartj\/ehu331","volume":"36","author":"D Atar","year":"2015","unstructured":"Atar D, Arheden H, Berdeaux A, Bonnet JL, Carlsson M, Clemmensen P, et al. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. Eur Heart J. 2015;36:112\u20139.","journal-title":"Eur Heart J"},{"key":"936_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373:1021\u201331.","journal-title":"N Engl J Med"},{"key":"936_CR19","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/pr.113.008300","volume":"66","author":"P Ferdinandy","year":"2014","unstructured":"Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R. Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014;66:1142\u201374.","journal-title":"Pharmacol Rev"},{"key":"936_CR20","doi-asserted-by":"publisher","first-page":"H1580","DOI":"10.1152\/ajpheart.00379.2008","volume":"295","author":"O Bouhidel","year":"2008","unstructured":"Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in Ob\/Ob mice. Am J Physiol Heart Circ Physiol. 2008;295:H1580\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"936_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.atherosclerosis.2005.11.023","volume":"188","author":"EK Iliodromitis","year":"2006","unstructured":"Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L, et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis. 2006;188:356\u201362.","journal-title":"Atherosclerosis"},{"key":"936_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbrc.2015.01.084","volume":"458","author":"N Wu","year":"2015","unstructured":"Wu N, Zhang X, Jia P, Jia D. Hypercholesterolemia abrogates the protective effect of ischemic postconditioning by induction of apoptosis and impairment of activation of reperfusion injury salvage kinase pathway. Biochem Biophys Res Commun. 2015;458:148\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"936_CR23","doi-asserted-by":"publisher","first-page":"e76652","DOI":"10.1371\/journal.pone.0076652","volume":"8","author":"Y Xu","year":"2013","unstructured":"Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, Wang WN, et al. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS One. 2013;8:e76652.","journal-title":"PLoS One"},{"key":"936_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00395-014-0403-3","volume":"109","author":"T Yetgin","year":"2014","unstructured":"Yetgin T, Magro M, Manintveld OC, Nauta ST, Cheng JM, den Uil CA, et al. Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning. Basic Res Cardiol. 2014;109:403.","journal-title":"Basic Res Cardiol"},{"key":"936_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/bcp.13053","volume":"82","author":"JM Siller-Matula","year":"2016","unstructured":"Siller-Matula JM, Specht S, Kubica J, Alexopoulos D, De Caterina R, Hobl EL, et al. Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. Br J Clin Pharmacol. 2016;82:1343\u201350.","journal-title":"Br J Clin Pharmacol"},{"key":"936_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/eurheartj\/ehv547","volume":"37","author":"J Kubica","year":"2016","unstructured":"Kubica J, Adamski P, Ostrowska M, Sikora J, Kubica JM, Sroka WD, et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction. Eur Heart J. 2016;37:245\u201352.","journal-title":"Eur Heart J"},{"key":"936_CR27","doi-asserted-by":"crossref","unstructured":"Parodi G, Bellandi B, Xanthopoulou I, Capranzano P, Capodanno D, Valenti R, et al. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ Cardiovasc Interv. 2015;8:1-6.","DOI":"10.1161\/CIRCINTERVENTIONS.114.001593"},{"key":"936_CR28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"G Montalescot","year":"2014","unstructured":"Montalescot G, Van \u2018t Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371:1016\u201327.","journal-title":"N Engl J Med"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/eurheartj\/ehv567","volume":"37","author":"E Puymirat","year":"2016","unstructured":"Puymirat E, Lamhaut L, Bonnet N, Aissaoui N, Henry P, Cayla G, et al. Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality. Eur Heart J. 2016;37:1063\u201371.","journal-title":"Eur Heart J"},{"key":"936_CR30","doi-asserted-by":"crossref","unstructured":"Bonin M, Mewton N, Roubille F, Morel O, Cayla G, Angoulvant D, et al. Effect and safety of morphine use in acute anterior ST-segment elevation myocardial infarction. J Am Heart Assoc. 2018;7:1-8.","DOI":"10.1161\/JAHA.117.006833"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0936-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:14:10Z","timestamp":1571426050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0936-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0936-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethical principles stated in the Declaration of Helsinki and good clinical practice principles. The protocol was approved by an ethics committee (institutional review board of the Pitie-Salpetriere hospital, Paris, France) and all patients gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"193"}}